Squamous cell carcinoma of esophagus
Information
- Disease name
- Squamous cell carcinoma of esophagus
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04196075 | Completed | Phase 3 | The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer | March 1, 2018 | June 30, 2021 |
NCT00165490 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer | August 2004 | November 2014 |
NCT05759325 | Not yet recruiting | An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma | March 2023 | December 2026 | |
NCT01248299 | Terminated | Phase 2 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. | January 2011 | January 2017 |
NCT02353936 | Unknown status | Phase 2 | A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus | January 2015 | January 2020 |
NCT02041819 | Withdrawn | Phase 2 | Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus | February 2014 | January 2017 |
NCT02033538 | Withdrawn | Phase 2 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus | January 2014 | December 2016 |